1
5
Nature conservation and nature experiences for protected areas: Developing socio-economic monitoring together
more
Stories about Forschung
Hagleitner Hygiene International GmbH
Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year
moreLess than 30 days left to apply – don’t miss your chance
One documentmoreBiomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase
Vienna, Austria (ots) - Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a ...
moreAcousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...
morecanSERV Open Call relaunches: Apply now for Free Access to Cutting-Edge Cancer Research Services
One documentmore
Data4Life releases Data2Evidence as open source: a new chapter for global health research
moreZEISS Research Microscopy Solutions
ZEISS Lightfield 4D for instant volumetric high-speed imaging / Capturing physiological and neuronal processes in 3D
moreBriya Expands Access to European Real-World Data Through Strategic Partnership with Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy (ots/PRNewswire) - Briya, a leading healthcare data retrieval network, is proud to announce a strategic partnership with Casa Sollievo della Sofferenza, one of Italy's premier hospitals renowned for its advanced medical care and research initiatives. This collaboration marks a significant ...
moreCO.DON GmbH partners in EU-Funded Project to Advance 3D Bioprinting for Tissue Regeneration
Teltow (ots) - The EU-funded micro2MACRO (m2M) project, launched in December 2024, aims to advance tissue regeneration through an innovative bioprinting platform. m2M focuses on precisely patterning cell aggregates and microtissues into stable, customizable grafts that remodel into functional tissues after implantation. The project unites leading academic institutions, ...
moreEU4Regions - How EU cohesion policy solves local challenges and strengthens cross-border cooperation
Brussels (ots) - A new project is being launched to promote the European Union’s cohesion policy aimed at strengthening economic, social and territorial unity across the continent’s regions. The ‘EU4Regions’ project will create comprehensive multimedia and journalistic content that makes the impact of the ...
moreAsklepios Kliniken GmbH & Co. KGaA
Nomination period for the Broermann Medical Innovation Award started
Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is ...
more
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
more
25The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment
moreAustria is a hotspot: 25 practical labs for the circular economy
Graz, Austria (ots) - With more than 25 test labs in Austria, the first-ever “Circularity Labs Austria” map demonstrates a concentration in the field of the circular economy that is probably unique in Europe. Most of them, and almost all of them on an industrial, large-scale, are located around the University of Leoben. Companies from Austria and abroad are testing here which raw materials from waste can be used in ...
moreGrünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
moreDeutsche Bundesstiftung Umwelt (DBU)
Encouraging people to protect the earth / DBU honours Franziska Tanneberger and Thomas Speidel
Osnabrück, Germany (ots) - Ways to better protect the planet are currently being debated at the World Summit on Nature in Cali, Colombia, and soon at the World Climate Conference in Baku, Azerbaijan. Today in Mainz, two people are demonstrating what practical solutions can look like: Peatland researcher Dr Franziska Tanneberger and electrical engineer Thomas Speidel ...
more
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
moreExtreme Rainfall Poses Health Risks
Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...
morecanSERV relaunches Open Call for Service Provision
One documentmoreAcousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
moreESSL - European Severe Storms Laboratory
Europe needs Twisters campaign
Wiener Neustadt, Austria (ots) - Researchers from all over Europe are organising high-density measurements of severe storms, similar to the new film Twisters. Severe weather researchers from 14 European countries want to work together to get to the bottom of severe thunderstorms so that they can provide better warnings in future. To this aim, they are currently planning the largest European measurement campaign on severe thunderstorms to date. "We want to use the latest ...
morePress Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...
more
Kontrast Personalberatung GmbH
Postdocs for Core Informatics & PhD Students for Cyber-Physical Systems Wanted
Hamburg (ots) - Karlsruhe Institute of Technology launches two innovative research projects in cooperation with the Helmholtz Association The Karlsruhe Institute of Technology (KIT), one of Europe's leading technical universities, announces the launch of two groundbreaking research projects, which set new standards in basic research on cyber-physical systems and core ...
moreResearchers: The future of democracy is on the ballot in Europe
morecanSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmoreLAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmoreBosch Healthcare Solutions GmbH
Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
more
1234Next